Amgen has announced a deal with the US government that will lower the company’s prescription drug costs for US patients while ...

GlaxoSmithKline’s (GSK) Nucala (mepolizumab) has been approved by the MHRA to treat adults with uncontrolled chronic ...

The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product ...

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, ...

The event will include a Keynote Panel discussion with noted speakers from the NHS, the King’s Fund, the ABPI and the ABHI ...

Novartis has announced an agreement with the US government to lower the prices of its medicines in the US and support ...

As part of the three-year agreement, Gilead has agreed to take a series of actions that align with the government’s new drug ...

On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, ...

Every year, we’re met with restructuring, hiring freezes, and portfolio cuts. And every year we tell ourselves the same story ...

Novo Nordisk’s Wegovy (semaglutide) pill has been approved by the US FDA as an oral weight loss medication. In addition to ...

Merck (known as MSD outside the US) has announced an agreement with the US government to provide key products to patients at ...

Radical Departures specialises in interactive medical and healthcare communications. Our team combines creativity with extensive medical and scientific experience. We have been designing and ...